Literature DB >> 21505300

Most adults seek urgent healthcare when acquiring HIV-1 and are frequently treated for malaria in coastal Kenya.

Eduard J Sanders1, Elizabeth Wahome, Mary Mwangome, Alexander N Thiong'o, Haile S Okuku, Matthew A Price, Lorraine Wamuyu, Michael Macharia, R Scott McClelland, Susan M Graham.   

Abstract

BACKGROUND: Acute HIV-1 infection (AHI) may present with symptoms for which urgent healthcare is sought. However, little is known about healthcare seeking around the time of HIV-1 seroconversion in sub-Saharan Africa.
METHODS: Review of clinical, counselling, treatment and laboratory records of previously HIV-1 seronegative at-risk adults, followed at monthly or 3-monthly visits, who seroconverted and enrolled in an AHI cohort. All HIV-seronegative plasma samples were tested for p24 antigen (p24) and stored preseroconversion samples for HIV-1 RNA (RNA). Factors associated with malaria treatment while acquiring HIV-1 were evaluated in multiple logistic regression.
RESULTS: Sixty men and 12 women (95% of 75 seroconverters) were evaluated, including 43 (60%) with either p24-positive or RNA-positive or HIV-1 discordant rapid antibodies prior to seroconversion. Prior to diagnosis, 54 patients (75%) reported fever and 50 (69%) sought urgent care for symptomatic illness, including 23 (32%) who sought care in a nonresearch setting. Twenty-nine patients (40%) received presumptive malaria treatment. Only 24% of febrile patients were tested for malaria parasites. All documented smear results were negative. Malaria treatment was strongly associated with fever [adjusted odds ratio (aOR): 46, 95% confidence interval (CI): 3-725] and nonresearch setting (aOR: 5, 95% CI: 3-64). AHI was suspected in six (12%) patients who presented for urgent care during research evaluation.
CONCLUSIONS: The majority of adults with AHI seek urgent healthcare. These individuals are often presumptively treated for malaria. Improved recognition of AHI in adults presenting for care may offer opportunities for optimizing HIV prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505300     DOI: 10.1097/QAD.0b013e3283474ed5

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  28 in total

1.  Brief Report: Health-Seeking Behavior and Symptoms Associated With Early HIV Infection: Results From a Population-Based Cohort in Southern Malawi.

Authors:  Sara E Yeatman; Risa M Hoffman; Abdallah Chilungo; Sydney R Lungu; Hazel C Namadingo; Angela F Chimwaza; Jenny A Trinitapoli
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

Review 2.  The HIV treatment cascade in acutely infected people: informing global guidelines.

Authors:  Sarah E Rutstein; Christopher J Sellers; Jintanat Ananworanich; Myron S Cohen
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.283

3.  Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009.

Authors:  Patrick S Sullivan; Ulgen Fideli; Kristin M Wall; Elwyn Chomba; Cheswa Vwalika; William Kilembe; Amanda Tichacek; Nicole Luisi; Joseph Mulenga; Eric Hunter; Debrah Boeras; Susan Allen
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

Review 4.  Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.

Authors:  Larry W Chang; David Serwadda; Thomas C Quinn; Maria J Wawer; Ronald H Gray; Steven J Reynolds
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

5.  High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among MSM.

Authors:  Eduard J Sanders; Haile S Okuku; Adrian D Smith; Mary Mwangome; Elizabeth Wahome; Gregory Fegan; Norbert Peshu; Elisabeth M van der Elst; Matthew A Price; R Scott McClelland; Susan M Graham
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

6.  Early Diagnosis of HIV-1 and HIV-2 Using Cobas HIV-1/HIV-2 Qualitative Test: A Novel Qualitative Nucleic Acid Amplification Test for Plasma, Serum, and Dried Blood Spot Specimens.

Authors:  Lucia Hans; Nicole von Allmen; Anke Edelmann; Jörg Hofmann; Alex Y Nilsson; Christian O Simon; Britta Seiverth; Peter Gohl; Sergio Carmona
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-15       Impact factor: 3.771

Review 7.  Management of adolescents and adults with febrile illness in resource limited areas.

Authors:  John A Crump; Sandy Gove; Christopher M Parry
Journal:  BMJ       Date:  2011-08-08

8.  Modeling the Impact of HIV-1 Nucleic Acid Testing Among Symptomatic Adult Outpatients in Kenya.

Authors:  Deven T Hamilton; Clara Agutu; Joseph B Babigumira; Elise van der Elst; Amin Hassan; Evanson Gichuru; Peter Mugo; Carey Farquhar; Thumbi Ndung'u; Martin Sirengo; Wairimu Chege; Steven M Goodreau; Adam Elder; Eduard J Sanders; Susan M Graham
Journal:  J Acquir Immune Defic Syndr       Date:  2022-05-05       Impact factor: 3.771

Review 9.  Emerging themes for sensitivity training modules of African healthcare workers attending to men who have sex with men: a systematic review.

Authors:  Maartje Dijkstra; Elise M van der Elst; Murugi Micheni; Evanson Gichuru; Helgar Musyoki; Zoe Duby; Joep M A Lange; Susan M Graham; Eduard J Sanders
Journal:  Int Health       Date:  2015-01-16       Impact factor: 2.473

10.  Evaluation of an empiric risk screening score to identify acute and early HIV-1 infection among MSM in Coastal Kenya.

Authors:  Elizabeth Wahome; Greg Fegan; Haile S Okuku; Peter Mugo; Matthew A Price; Grace Mwashigadi; Alexander Thiong'o; Susan M Graham; Eduard J Sanders
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.